يحاول ذهب - حر
Anthem puts spotlight on a red hot mkt
July 16, 2025
|Mint New Delhi
In the grey market, Anthem shares were quoting at ₹679—about 19% above the issue price
The initial public offering of Bengaluru-based Anthem Biosciences, a contract research and innovation provider, has thrown the spotlight on India's contract development and manufacturing organization (CDMO) space.
On Day 1, the IPO was subscribed 0.7x overall. Among non-institutional investors, bids above ₹10 lakh were subscribed 1.37x, and those between ₹2 lakh and ₹10 lakh saw nearly 2x subscription, NSE data showed.
In the grey market, Anthem shares were quoting at ₹679—about 19% above the issue price, according to IPO data platform Investor Gain.
The excitement isn't limited to Anthem. Shares of CDMO players have been surging. From July 2023 to mid-July 2024, Divi's Laboratories gained 49%, Aarti Pharmalabs rose 53%, Piramal Pharma climbed 38%, and Cohance Lifesciences advanced 22%.
In contrast, generic pharma majors underwhelmed. Sun Pharma is up just 7%, Cipla and Dr. Reddy's have slipped 2% and 7% respectively, while Torrent Pharma posted a modest 15.5% rise and Aurobindo Pharma fell 14%.
هذه القصة من طبعة July 16, 2025 من Mint New Delhi.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint New Delhi
Mint New Delhi
Morgan Stanley, MUFG start $1 bn Vena India sale process
GIP to fully exit Vena Energy India as global capital flows into India’s clean energy market
2 mins
October 15, 2025
Mint New Delhi
India needs $217 bn for its nuclear goal
India will require nearly ₹19.3 trillion ($217 billion) of investment to reach its target of installing 100 gigawatts of nuclear power capacity by 2047, according to a power ministry panel’s report, published Tuesday.
1 min
October 15, 2025
Mint New Delhi
How Taylor Swift rewrote the business of record sales
For almost a decade, Adele’s 25 has held the record for first-week album sales with nearly 3.5 million. That mark appeared insurmountable until Taylor Swift released The Life of a Showgirl on Oct. 3. The pop star blew past Adele's total in five days, ultimately earning a hair more than 4-million sales.
4 mins
October 15, 2025
Mint New Delhi
TV old guards bet on short-video boom
As TV suffers a slow decline and audiences rush to dopamine-fuelled shortspan entertainment, makers of hit soap operas that dominated Indian entertainment are turning to microdramas and other short video and audio formats.
2 mins
October 15, 2025
Mint New Delhi
How innovation sustains growth: Mokyr richly deserves his Nobel
Knowledge absorption holds the key and that could depend on a society's openness to ideas and readiness to embrace change
4 mins
October 15, 2025
Mint New Delhi
Roche moves SC against Natco over Risdiplam sale in India
Swiss drugmaker Roche has moved the Supreme Court, seeking to restrain Natco Pharma from selling the generic version of its lifesaving spinal muscular atrophy (SMA) drug Risdiplam in India.
1 mins
October 15, 2025
Mint New Delhi
Neither lawyers nor engineers run India and that’s fine
In his book, Breakneck: China’s Quest to Engineer the Future, Dan Wang describes two distinct approaches to development.
3 mins
October 15, 2025
Mint New Delhi
Ficci elects Anant Goenka as its head
Industry chamber Federation of Indian Chambers of Commerce & Industry (Ficci) on Tuesday announced RPG Group vice chairman Anant Goenka as its president-elect for 2025-26.
1 min
October 15, 2025
Mint New Delhi
Foxconn to ramp up local component mfg in India
The Taiwanese contract manufacturer has committed $11.5 bn to India over the past decade
2 mins
October 15, 2025
Mint New Delhi
Railways starts door-to-door delivery of freight, parcels
The move is part of railways' efforts to become a comprehensive logistics player
1 mins
October 15, 2025
Listen
Translate
Change font size